🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ascites is a cardinal and debilitating complication in patients with acute-...
Status
Not Yet Recruiting
Location
Institute of Liver and Biliary Sciences
Start Date
2026-02-05
Trial ID
NCT07422948
Treatments Being Tested
Steroid is the treatment of choice in patients with severe alcoholic hepati...
Status
Terminated
Location
Chuncheon Sacred Heart hospital
Start Date
2015-07
Trial ID
NCT02442180
Treatments Being Tested
The main purpose of the study is to test if taking a study drug called emri...
Status
Terminated
Location
Indiana University
Start Date
2013-07
Trial ID
NCT01912404
A phase 2a double-blind, randomized, placebo-controlled, multicenter, proof...
Status
Unknown
Location
Multiple Locations
Start Date
2021-12
Trial ID
NCT04620148
The primary purpose of this study is to evaluate the safety and efficacy of...
Status
Recruiting
Location
University of Alabama at Birmingham (UAB) Hospital
Start Date
2026-01-29
Trial ID
NCT07428538
Treatments Being Tested
Eligible participants will be asked to take a placebo/treatment capsule for...
Status
Recruiting
Location
Cleveland Clinic
Start Date
2022-09-01
Trial ID
NCT05018481
Treatments Being Tested
Background/Aims: The investigators explored the therapeutic effects of pro...
Status
Unknown
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT02335632
Treatments Being Tested
Only patients suffering from a severe form of alcoholic hepatitis (Maddrey'...
Status
Recruiting
Location
CHU de Lille, Hôpital Huriez
Start Date
2026-05-22
Trial ID
NCT06956482
This multicenter, randomized, double blinded, placebo-controlled clinical t...
Status
Completed
Location
Mayo Clinic
Start Date
2020-07-10
Trial ID
NCT04072822
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, phase 2b clinical T...
Status
Completed
Location
University of Alabama at Birmingham (UAB) Hospital
Start Date
2021-01-22
Trial ID
NCT04563026
Treatments Being Tested